Back

Nationwide Children’s Hospital

  • Cell- and Tissue-Based Therapy

2025 PGROD: Cell Therapy for Cancer and Beyond by Dean Lee, MD, PhD

Objective(s): 1 Recognize the breadth of cell types, donor sources, and genetic modification approaches that constitute cellular therapies. 2 Identify the key features of target diseases that are amenable to cellular therapies. 3 Discuss specific cellular therapies that are being developed at Nationwide Children’s Hospital.Location: Nationwide Children’s Hospital Conference CenterSpecialties: General PediatricsFaculty Disclosures:Dean Lee, MD (Stocks or stock options, excluding diversified mutual funds-Courier Therapeutics (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Kiadis Pharma (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Kiadis Pharma (Relationship has ended)|Grant or research support-Kiadis Pharma|Royalties or Patent Beneficiary-Kiadis Pharma|Paid consultant-Sanofi|Grant or research support-Avidicure|Stocks or stock options, excluding diversified mutual funds-Avidicure|Advisor-Avidicure – 02/10/2025)Download Handout

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 creditSocial WorkUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • Released
    Feb 17, 2025
  • Last day to claim credit
    Feb 18, 2028 1 year left